中国全科医学
中國全科醫學
중국전과의학
CHINESE GENERAL PRACTICE
2014年
23期
2722-2725
,共4页
陈永利%姜华%陈闽荔%陈树涛%丛洪良%付乃宽
陳永利%薑華%陳閩荔%陳樹濤%叢洪良%付迺寬
진영리%강화%진민려%진수도%총홍량%부내관
贫血%肾功能不全,急性%血管成形术,经腔,经皮冠状动脉%造影剂
貧血%腎功能不全,急性%血管成形術,經腔,經皮冠狀動脈%造影劑
빈혈%신공능불전,급성%혈관성형술,경강,경피관상동맥%조영제
Anemia%Renal insufficiency,acute%Angioplasty,transluminal,percutaneous coronary%Contrast media
目的:探讨贫血与经皮冠状动脉介入术( PCI)后对比剂诱导的急性肾损伤( CI-AKI)的关系。方法选取天津市胸科医院心内科2008年1月-2010年5月行PCI的冠心病患者1500例,于PCI前及PCI后72 h内检测血肌酐水平。CI-AKI定义为PCI后72 h内测定血肌酐较术前水平增加44.2μmol/L或升高25%以上。贫血定义为血红蛋白( Hb)<110 g/L(女性)或<120 g/L(男性)。以各项临床及实验室检查指标为自变量,分别以CI-AKI及贫血为因变量,应用多元 Logistic 回归分析CI-AKI及贫血的危险因素。结果1500例行 PCI 患者中共有295例(19.7%)发生贫血,246例(16.4%)发生CI-AKI。贫血组与非贫血组CI-AKI发病率分别为29.2%(86/295)和13.3%(160/1205)(P<0.05);伴有肾功能不全者中,贫血组和非贫血组 CI-AKI发病率分别为39.4%(26/66)和24.6%(46/187)(P<0.05);在肾功能正常者中,贫血组和非贫血组CI-AKI发病率分别为26.2%(60/229)和11.2%(114/1018)(P<0.05)。多元Logistic回归分析显示,贫血是PCI后发生CI-AKI的危险因素〔OR(95%CI)=1.85(1.31,2.61)〕,而高龄、肾功能不全及左心室射血分数( LVEF)≤50%是冠心病患者发生贫血的危险因素〔OR(95%CI)=1.47(1.37,1.70);1.93(1.41,2.65);1.62(1.20,2.17)〕。结论无论患者是否伴有肾功能不全,贫血均是冠心病患者PCI后发生CI-AKI的危险因素。
目的:探討貧血與經皮冠狀動脈介入術( PCI)後對比劑誘導的急性腎損傷( CI-AKI)的關繫。方法選取天津市胸科醫院心內科2008年1月-2010年5月行PCI的冠心病患者1500例,于PCI前及PCI後72 h內檢測血肌酐水平。CI-AKI定義為PCI後72 h內測定血肌酐較術前水平增加44.2μmol/L或升高25%以上。貧血定義為血紅蛋白( Hb)<110 g/L(女性)或<120 g/L(男性)。以各項臨床及實驗室檢查指標為自變量,分彆以CI-AKI及貧血為因變量,應用多元 Logistic 迴歸分析CI-AKI及貧血的危險因素。結果1500例行 PCI 患者中共有295例(19.7%)髮生貧血,246例(16.4%)髮生CI-AKI。貧血組與非貧血組CI-AKI髮病率分彆為29.2%(86/295)和13.3%(160/1205)(P<0.05);伴有腎功能不全者中,貧血組和非貧血組 CI-AKI髮病率分彆為39.4%(26/66)和24.6%(46/187)(P<0.05);在腎功能正常者中,貧血組和非貧血組CI-AKI髮病率分彆為26.2%(60/229)和11.2%(114/1018)(P<0.05)。多元Logistic迴歸分析顯示,貧血是PCI後髮生CI-AKI的危險因素〔OR(95%CI)=1.85(1.31,2.61)〕,而高齡、腎功能不全及左心室射血分數( LVEF)≤50%是冠心病患者髮生貧血的危險因素〔OR(95%CI)=1.47(1.37,1.70);1.93(1.41,2.65);1.62(1.20,2.17)〕。結論無論患者是否伴有腎功能不全,貧血均是冠心病患者PCI後髮生CI-AKI的危險因素。
목적:탐토빈혈여경피관상동맥개입술( PCI)후대비제유도적급성신손상( CI-AKI)적관계。방법선취천진시흉과의원심내과2008년1월-2010년5월행PCI적관심병환자1500례,우PCI전급PCI후72 h내검측혈기항수평。CI-AKI정의위PCI후72 h내측정혈기항교술전수평증가44.2μmol/L혹승고25%이상。빈혈정의위혈홍단백( Hb)<110 g/L(녀성)혹<120 g/L(남성)。이각항림상급실험실검사지표위자변량,분별이CI-AKI급빈혈위인변량,응용다원 Logistic 회귀분석CI-AKI급빈혈적위험인소。결과1500례행 PCI 환자중공유295례(19.7%)발생빈혈,246례(16.4%)발생CI-AKI。빈혈조여비빈혈조CI-AKI발병솔분별위29.2%(86/295)화13.3%(160/1205)(P<0.05);반유신공능불전자중,빈혈조화비빈혈조 CI-AKI발병솔분별위39.4%(26/66)화24.6%(46/187)(P<0.05);재신공능정상자중,빈혈조화비빈혈조CI-AKI발병솔분별위26.2%(60/229)화11.2%(114/1018)(P<0.05)。다원Logistic회귀분석현시,빈혈시PCI후발생CI-AKI적위험인소〔OR(95%CI)=1.85(1.31,2.61)〕,이고령、신공능불전급좌심실사혈분수( LVEF)≤50%시관심병환자발생빈혈적위험인소〔OR(95%CI)=1.47(1.37,1.70);1.93(1.41,2.65);1.62(1.20,2.17)〕。결론무론환자시부반유신공능불전,빈혈균시관심병환자PCI후발생CI-AKI적위험인소。
Objective To investigate the relationship of anemia to contrast induced-acute kidney injury( CI-AKI) after percutaneous coronary intervention( PCI). Methods A total of 1 500 patients from Department of Cardiology,Tianjin Chest Hospital were selected,which with coronary heart disease(CHD)underwent PCI from January 2008 to May 2010. Serum creatinine(Scr)level was determined before PCI and 72 h after. CI-AKI was defined as an absolute increase by≥44. 2μmol/L or a relative increase by≥25% in Scr within 72 hours after PCI. Anemia was defined as a level of hemoglobin( Hb)<120 g/L in man or <110 g/L in woman. Taking clinical and laboratory indicators as independent variables,CI-AKI and anemia as dependent variables,multivariate Logistic regression analysis was performed to identify risk factors of CI-AKI and anemia. Re-sUlts Among the 1 500 patients,295(19. 7%)had anemia,246(16. 4%)had CI -AKI. The CI -AKI incidences of groups anemia,non-anemia were 29. 2%(86/295),13. 3%(160/1 205),respectively(P<0. 05). CI-AKI incidences of groups anemia,non-anemia were 39. 4%(26/66),24. 6%(46/187),respectively,in the patients combined with renal dysfunction(P<0. 05),and 26. 2%(60/229),11. 2%(114/1 018),respectively,in those with normal renal function (P<0. 05). By multivariate Logistic regression analysis,anemia was a risk factor of CI-AKI after PCI〔OR(95%CI) =1. 85(1. 31,2. 61)〕,and advanced age,renal dysfunction,LVEF≤50% were risk factors of anemia in CHD patients〔OR (95%CI) = 1. 47(1. 37,1. 70);1. 93(1. 41,2. 65);1. 62(1. 20,2. 17)〕. ConclUsion Anemia is a risk factor of CI-AKI in CHD patients after PCI regardless of whether the patients have renal dysfunction or not.